2012 News Releases
Nov 29, 2012:
iCo Therapeutics Announces Third Quarter 2012 Financial Results
Oct 12, 2012:
iCo Therapeutics' Oral Amphotericin B Delivery System to be Presented at AAPS with Updated Patent Position
Sep 5, 2012:
iCo Therapeutics to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
Aug 29, 2012:
iCo Therapeutics Announces Second Quarter 2012 Financial Results
Jul 13, 2012:
iCo Therapeutics Closes $2.55 Million Financing
Jul 5, 2012:
iCo Therapeutics to Raise $2.55 Million
Jul 4, 2012:
iCo Therapeutics Announces Overnight Marketed Equity Offering
May 31, 2012:
iCo Therapeutics receives funding from the Government of Canada for the pre-clinical and clinical development of its Oral Amphotericin B Delivery System for the treatment of HIV/AIDS
May 30, 2012:
iCo Therapeutics Announces First Quarter 2012 Financial Results
Apr 16, 2012:
iCo Therapeutics Announces Year End 2011 Financial Results
Mar 28, 2012:
iCo Therapeutics and JDRF Team Up to Support Phase II Clinical Trial iDEAL for Diabetic Macular Edema
Mar 27, 2012:
iCo Therapeutics CEO to Present at Retinal Physician Symposium 2012
Mar 5, 2012:
iCo Therapeutics Appoints Douglas Janzen to Board of Directors
Jan 17, 2012:
iCo Therapeutics Retains Crescendo Communications
Copyright 2015 ICO Therapeutics | Disclaimer